87 related articles for article (PubMed ID: 32819762)
1. Erratum to "Prostate MRI radiomics: A systematic review and radiomic quality score assessment" [Eur. J. Radiol. 129 (2020) 109095].
Stanzione A; Gambardella M; Cuocolo R; Ponsiglione A; Romeo V; Imbriaco M
Eur J Radiol; 2020 Oct; 131():109208. PubMed ID: 32819762
[No Abstract] [Full Text] [Related]
2. Corrigendum to "Atherosclerotic carotid artery disease Radiomics: A systematic review with meta-analysis and radiomic quality score assessment" [Eur. J. Radiol. 177 (2024) 111547].
Vacca S; Scicolone R; Gupta A; Allan Wasserman B; Song J; Nardi V; Yang Q; Benson J; Lanzino G; Paraskevas KI; Suri JS; Saba L
Eur J Radiol; 2024 Jun; 177():111583. PubMed ID: 38944908
[No Abstract] [Full Text] [Related]
3. Erratum to 'Prostate cancer local staging using biparametric MRI: Assessment and comparison with multiparametric MRI' [Eur. J. Radiol. 132 (2020) 109350].
Christophe C; Montagne S; Bourrelier S; Roupret M; Barret E; Rozet F; Comperat E; Coté JF; Lucidarme O; Cussenot O; Granger B; Renard-Penna R
Eur J Radiol; 2020 Dec; 133():109417. PubMed ID: 33229110
[No Abstract] [Full Text] [Related]
4. Erratum to "Biparameteric prostate MRI and clinical indicators predict clinically significant prostate cancer in men with "gray zone" PSA levels" [Eur. J. Radiol. 127 (2020) 108977].
Wei CG; Chen T; Zhang YY; Pan P; Dai GC; Yu HC; Yang S; Jiang Z; Tu J; Lu ZH; Shen JK; Zhao WL
Eur J Radiol; 2020 Aug; 129():109129. PubMed ID: 32580910
[No Abstract] [Full Text] [Related]
5. Tracking tumor biology with radiomics: A systematic review utilizing a radiomics quality score.
Sanduleanu S; Woodruff HC; de Jong EEC; van Timmeren JE; Jochems A; Dubois L; Lambin P
Radiother Oncol; 2018 Jun; 127(3):349-360. PubMed ID: 29779918
[TBL] [Abstract][Full Text] [Related]
6. Corrigendum to "MRI radiomics for the preoperative evaluation of lymphovascular invasion in breast cancer: A meta-analysis" [Eur. J. Radiol. 168 (2023) 111127].
Ma Q; Li Z; Li W; Chen Q; Liu X; Feng W; Lei J
Eur J Radiol; 2024 Jan; 170():111226. PubMed ID: 38056346
[No Abstract] [Full Text] [Related]
7. Erratum to "Non-palpable incidentally found testicular tumors: Differentiation between benign, malignant, and burned-out tumors using dynamic contrast-enhanced MRI" [Eur. J. Radiol. 85(11) (2016) 2072-2082].
El Sanharawi I; Correas JM; Glas L; Ferlicot S; Izard V; Ducot B; Bellin MF; Benoît G; Rocher L
Eur J Radiol; 2017 Mar; 88():171. PubMed ID: 28069337
[No Abstract] [Full Text] [Related]
8. Corrigendum to "The role of AI in prostate MRI quality and interpretation: Opportunities and challenges" [Eur. J. Radiol. 165 (2023) 110887].
Kim H; Kang SW; Kim JH; Nagar H; Sabuncu M; Margolis DJA; Kyo Kim C
Eur J Radiol; 2024 Jul; 177():111585. PubMed ID: 38959558
[No Abstract] [Full Text] [Related]
9. Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings.
Shiradkar R; Ghose S; Jambor I; Taimen P; Ettala O; Purysko AS; Madabhushi A
J Magn Reson Imaging; 2018 Dec; 48(6):1626-1636. PubMed ID: 29734484
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer radiomics and the promise of radiogenomics.
Stoyanova R; Takhar M; Tschudi Y; Ford JC; Solórzano G; Erho N; Balagurunathan Y; Punnen S; Davicioni E; Gillies RJ; Pollack A
Transl Cancer Res; 2016 Aug; 5(4):432-447. PubMed ID: 29188191
[TBL] [Abstract][Full Text] [Related]
11. Multicenter evaluation of MRI-based radiomic features: A phantom study.
Rai R; Holloway LC; Brink C; Field M; Christiansen RL; Sun Y; Barton MB; Liney GP
Med Phys; 2020 Jul; 47(7):3054-3063. PubMed ID: 32277703
[TBL] [Abstract][Full Text] [Related]
12. Rectal wall MRI radiomics in prostate cancer patients: prediction of and correlation with early rectal toxicity.
Abdollahi H; Mahdavi SR; Mofid B; Bakhshandeh M; Razzaghdoust A; Saadipoor A; Tanha K
Int J Radiat Biol; 2018 Sep; 94(9):829-837. PubMed ID: 29969358
[TBL] [Abstract][Full Text] [Related]
13. Erratum to "Inter-exam agreement and diagnostic performance of the Korean Thyroid Imaging Reporting and Data System for thyroid nodule assessment: Real-time versus static ultrasonography" [Eur. J. Radiol. 98 (2018) 14-19].
Bae JM; Hahn SY; Shin JH; Ko EY
Eur J Radiol; 2018 Apr; 101():193. PubMed ID: 29459049
[No Abstract] [Full Text] [Related]
14. Machine learning-based radiomic models to predict intensity-modulated radiation therapy response, Gleason score and stage in prostate cancer.
Abdollahi H; Mofid B; Shiri I; Razzaghdoust A; Saadipoor A; Mahdavi A; Galandooz HM; Mahdavi SR
Radiol Med; 2019 Jun; 124(6):555-567. PubMed ID: 30607868
[TBL] [Abstract][Full Text] [Related]
15. Discovery radiomics via evolutionary deep radiomic sequencer discovery for pathologically proven lung cancer detection.
Shafiee MJ; Chung AG; Khalvati F; Haider MA; Wong A
J Med Imaging (Bellingham); 2017 Oct; 4(4):041305. PubMed ID: 29021990
[TBL] [Abstract][Full Text] [Related]
16. Erratum to "Large-bowel obstruction: CT findings, pitfalls, tips and tricks" [Eur. J. Radiol. 130 (2020) 109155].
Verheyden C; Orliac C; Millet I; Taourel P
Eur J Radiol; 2020 Nov; 132():109284. PubMed ID: 33041082
[No Abstract] [Full Text] [Related]
17. Analysis of heterogeneity of peritumoral T2 hyperintensity in patients with pretreatment glioblastoma: Prognostic value of MRI-based radiomics.
Choi Y; Ahn KJ; Nam Y; Jang J; Shin NY; Choi HS; Jung SL; Kim BS
Eur J Radiol; 2019 Nov; 120():108642. PubMed ID: 31546124
[TBL] [Abstract][Full Text] [Related]
18. Preliminary utilization of radiomics in differentiating uterine sarcoma from atypical leiomyoma: Comparison on diagnostic efficacy of MRI features and radiomic features.
Xie H; Hu J; Zhang X; Ma S; Liu Y; Wang X
Eur J Radiol; 2019 Jun; 115():39-45. PubMed ID: 31084757
[TBL] [Abstract][Full Text] [Related]
19. Improving survival prediction of high-grade glioma via machine learning techniques based on MRI radiomic, genetic and clinical risk factors.
Tan Y; Mu W; Wang XC; Yang GQ; Gillies RJ; Zhang H
Eur J Radiol; 2019 Nov; 120():108609. PubMed ID: 31606714
[TBL] [Abstract][Full Text] [Related]
20. Multiparametric MRI for Prostate Cancer Characterization: Combined Use of Radiomics Model with PI-RADS and Clinical Parameters.
Woźnicki P; Westhoff N; Huber T; Riffel P; Froelich MF; Gresser E; von Hardenberg J; Mühlberg A; Michel MS; Schoenberg SO; Nörenberg D
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32630787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
